Find uplifting stories about heroes, innovations, and solutions
8751 results for "breast cancer treatment"
The FDA just approved five new breast cancer treatments that give patients more hope than ever before, especially those facing the hardest-to-treat forms. Women who previously had few options now have powerful new weapons in their fight.
A groundbreaking combination therapy is giving women with HER2-positive metastatic breast cancer significantly more time, setting a new standard for first-line treatment. The DESTINY-Breast09 trial shows the treatment works across different patient groups, offering hope to thousands.
Women with triple-negative breast cancer just gained two powerful new treatment options that work better than standard chemotherapy at keeping the disease under control. The FDA approved Trodelvy alone and combined with immunotherapy as first-line treatments for this aggressive cancer type.
Women with an aggressive form of breast cancer now have two powerful new treatment options that work better than chemotherapy alone. The drugs represent the first major breakthrough in over 20 years for treating metastatic triple-negative breast cancer.
Women with aggressive double-positive breast cancer now have a powerful new treatment option after the FDA approved a therapy that extends the time without disease progression by more than 15 months. The breakthrough offers fresh hope for patients facing one of breast cancer's toughest challenges.
UK scientists created a simple blood test that tells doctors whether breast cancer treatment will work before therapy even begins. The breakthrough could spare patients from months of ineffective drugs and help them find treatments that actually work.
Scientists at Oregon Health & Science University created a molecule that shuts down a key enzyme cancer cells need to grow, causing tumors to shrink in mice with triple-negative breast cancer. The breakthrough could lead to new treatments for one of the deadliest forms of breast cancer.
The FDA just approved ENHERTU for early-stage breast cancer treatment, giving patients two new opportunities to stop the disease before it spreads. For the first time in years, doctors can offer new hope to the one in four patients who still face recurrence.
A breast cancer survivor is sharing her healing journey to give others hope. Emily Hester recently appeared on KARK 4 News to talk about her successful treatment for triple-positive breast cancer at CARTI.
Thousands of women with advanced breast cancer now have a powerful new option after hormone therapy stops working. The FDA just approved REVTORPYK for the most common type of breast cancer, offering hope to patients who previously had limited choices.
Scientists discovered how to beat triple-negative breast cancer at its own game by blocking an enzyme that helps tumors survive treatment. The approach not only damages cancer cells directly but also calls in the immune system for backup.
Scientists developed a simple blood test that reveals which breast cancer treatments will work before patients waste precious time on ineffective options. The breakthrough could help 2 million people diagnosed globally each year get the right treatment faster.
Scientists have discovered an antibody that successfully halted triple-negative breast cancer in laboratory models, offering hope for one of the most difficult cancers to treat. This breakthrough could lead to better treatment options for thousands of women facing this aggressive disease.
Scientists created a peptide that acts like a GPS tracker for metastatic breast cancer cells, successfully targeting and destroying them in mice without harming healthy tissue. The discovery could transform treatment for aggressive cancers that have spread beyond their original location.
The FDA just approved Enhertu for early-stage HER2-positive breast cancer, giving patients a powerful new treatment option before cancer spreads. This marks a major step forward in catching and treating breast cancer when it's most beatable.
A groundbreaking treatment for triple-negative breast cancer just got FDA approval, giving patients twice as long with controlled disease and six more months of life. Christina, who could barely walk months ago, just walked down the aisle at a wedding thanks to this drug.
Women with triple-negative breast cancer now have a powerful new first-line treatment option, thanks to research at Emory University. The FDA-approved combination therapy is giving hope to patients who once faced less than a year of survival.
More than a million breast cancer patients have benefited from CDK inhibitors, and researchers at Roswell Park are now working to extend these life-saving benefits to other cancer types. New drug combinations and precision medicine approaches could help more patients live longer with fewer side effects.
A personalized mRNA vaccine helped 11 women with aggressive breast cancer stay cancer-free for up to six years. The groundbreaking treatment trained their immune systems to recognize and fight cancer cells using their own tumor's genetic code.
Scientists have discovered a molecule that stops triple-negative breast cancer, the most aggressive form that often strikes younger women. The breakthrough treatment shows promise without the toxic side effects that plagued previous cancer therapies.
Showing 20 of 8751